Heart Failure Risk Among Children Born Preterm Persists Through Adulthood

April 06, 2021

An analysis of more than 4 million singleton births indicates children born at an early gestational age were at an increased risk of heart failure at multiple points throughout life when compared to their counterparts not considered preterm births.

Dasiglucagon (Zegalogue) Approved by FDA for Severe Hypoglycemia in Children and Adults

March 22, 2021

Zealand Pharma announced the US FDA approved dasiglucagon (Zegalogue) for treatment of severe hypoglycemia in patients with diabetes aged 6 and older and the injectable will be available as both an auto injector and a prefilled syringe.